This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
-
Newport Hospital, Newport, Rhode Island, United States, 02840
Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States, 02903
South County Hospital, Wakefield, Rhode Island, United States, 02879
Kent Hospital, Warwick, Rhode Island, United States, 02886
Landmark Hospital, Woonsocket, Rhode Island, United States, 02895
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 60 Years
FEMALE
No
Women and Infants Hospital of Rhode Island,
2029-03-01